Article

JOURNAL MENU
Cover
Journal Cover Page

RGUHS Nat. J. Pub. Heal. Sci Vol: 14  Issue: 2 eISSN:  pISSN

Case Report

Primary Pure Ovarian Choriocarcinoma Mimicking as Ruptured Ectopic Pregnancy: A Rare Case Report

 Lancelot Lobo1 , Kishan Prasad HL2 , Sujaya Prabhakar3

 1 Department of General Surgery, 2Department of Pathology,3 Department of Obstetrics & Gynaecology, K S Hegde Medical Academy of Nitte University, Mangalore, Karnataka, India.

Year: 2013, Volume: 3, Issue: 3, Page no. 181-183,
Views: 603, Downloads: 5
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

Primary choriocarcinoma of ovary is rare. It could be gestational or non-gestational in origin. The distinction between the two is difficult, but necessary, as the non-gestational type has a bad prognosis. We report a case of a pure ovarian choriocarcinoma, likely to be of gestational origin, treated by cytoreductive surgery in combination with post-operative chemotherapy. The patient received 4 cycles of Etoposide/ Metotrexate / Actinomycin D/ Cisplatin/ Etoposide (EMA-CE) regimen with a satisfactory decrease in the serum β-hCG level. There was no evidence of recurrence or metastasis after 6- months follow-up. Our case provides evidence that cytoreductive surgery in combination with post-operative chemotherapy is an effective therapeutic strategy for pure ovarian choriocarcinoma. The pure ovarian choriocarcinoma is aggressive with a high risk of metastasis, close follow-up with serum β-hCG and imaging examinations is essential.

<p>Primary choriocarcinoma of ovary is rare. It could be gestational or non-gestational in origin. The distinction between the two is difficult, but necessary, as the non-gestational type has a bad prognosis. We report a case of a pure ovarian choriocarcinoma, likely to be of gestational origin, treated by cytoreductive surgery in combination with post-operative chemotherapy. The patient received 4 cycles of Etoposide/ Metotrexate / Actinomycin D/ Cisplatin/ Etoposide (EMA-CE) regimen with a satisfactory decrease in the serum &beta;-hCG level. There was no evidence of recurrence or metastasis after 6- months follow-up. Our case provides evidence that cytoreductive surgery in combination with post-operative chemotherapy is an effective therapeutic strategy for pure ovarian choriocarcinoma. The pure ovarian choriocarcinoma is aggressive with a high risk of metastasis, close follow-up with serum &beta;-hCG and imaging examinations is essential.</p>
Keywords
Choriocarcinoma, non-gestational, ectopic pregnancy, gestational
Downloads
  • 1
    FullTextPDF
Article

none

Supporting File
No Pictures
References

none

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.